Skip to content

Effect of Bilberry (European Blueberries) and Grape Polyphenols on Cognition and Blood Parameters

Effect of Bilberry (European Blueberries) and Grape Polyphenols on Cognition and Blood Parameters in Normal, Aged Men With Subjective Memory Decline

Status
UNKNOWN
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00972972
Acronym
BLUEBERRY
Enrollment
61
Registered
2009-09-09
Start date
2006-12-31
Completion date
2009-12-31
Last updated
2009-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gene Expression, Memory

Keywords

fruit polyphenols, phytochemicals, neurocognition, neuropsychology, psychopharmacology, gene expression, biochemistry

Brief summary

The purpose of this study is to determine whether dietary intervention with blueberry and grape juice extracts in elderly men with subjective memory problems would raise performance on neuropsychological memory tests and change biomarker of muscle damage and whole blood gene expression profiles.

Detailed description

A number of studies have shown that increased dietary intake of fruits and vegetable extracts high in antioxidants (e.g., blueberries, strawberries and spinach) can retard and even reverse age-related decline in brain function and in cognitive and motor performance in rats. This is the first placebo-controlled human study to evaluate the effect of dietary intake of fruit polyphenols on neuropsychological test scores and whole blood gene regulation Sixty-two non-demented, non-depressed men (age 67-77 years) with subjective memory decline, were randomly assigned to a blueberry/grape juice- and placebo-group in a 9 week double blind intervention study. Pre- and post treatment assessment were measured with a computerised neuropsychological test battery (CANTAB), including tests for motor speed, visual reaction time, and spatial memory. Dietary habits were registered before intervention and several clinical biomarkers were measured in plasma/serum before and after the intervention. Pre- and post intervention-samples for measurement of gene regulation were also collected

Interventions

DIETARY_SUPPLEMENTbilberry (European blueberries) and red grape juice

Intervention juice: 50/50 combination of 300 ml bilberry (European blueberries) and red grape juice (Merlot grapes; Vitis Vinifera L.) per day for 9 weeks

DIETARY_SUPPLEMENTplacebo juice

Placebo juice: 300 ml, similar to the intervention juice as to taste, energy, salt, and carbohydrates

Sponsors

University of Oslo
CollaboratorOTHER
Ullevaal University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
67 Years to 77 Years
Healthy volunteers
Yes

Inclusion criteria

* men * age 67-77 years * gradual subjective memory decline * response to advertisement

Exclusion criteria

* head trauma with loss of consciousness and lasting symptoms * brain stroke within last 3 years * dementia, clinically diagnosed * signs of brain-degenerative disease * Mini Mental Status Examination score less than 26 * depression (MADRS; Montgomery Asberg Depression Rating Scale score above 20) * ongoing treatment for cancer (cytostatica)/diabetes * reported or observed serious mental illness * reported or observed use of narcotics (any, present or past) * reported or observed abuse of alcohol * visual, auditory, or motor handicaps of relevance for performance

Design outcomes

Primary

MeasureTime frame
neuropsychological test scores and whole blood gene regulationDecember 2006 - july 2007
whole blood gene regulation; parameters in blood2006 and 2007
neuropsychological test scores; whole blood gene regulation; parameters in blood2006 and 2007

Secondary

MeasureTime frame
gene expression of stress, repair and maintenance processes measured by whole genome microarray analysis in blood2007 and 2009

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026